Shell SHEL Receives Rating Upgrade Following ARC Resources Transaction Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles in Efficiency Push Amazon Allegedly Made Millions from NowIllegal Policy Sebi Chief Tuhin Kanta Pandey Advocates Bond ETFs and Tokenisation as Corporate Debt Fundraising Approaches Rs 9 Lakh Crore Taiwan Chip Stocks Rally Following Nvidias 150 Billion Spending Announcement Mainland Chinese Chip Firms Slide US Stock Futures and Bond Yields Retreat on Reports of Putins Nuclear Doctrine Update Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue Presurance Holdings Q1 2024 Earnings Surprise Profit Beats Estimates But Shares Slide on Revenue Disclosures Chevron Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies LLYVK Q4 2025 Earnings EPS Nearly Matches Estimates but Surprise Miss and Flat Revenue Weigh on Sentiment Labcorp Q1 2026 Earnings EPS Tops Estimates by Slim Margin Shares Edge Higher ISBA Q1 2026 Earnings Earnings Per Share Falls Well Short of Expectations Sarepta Therapeutics SRPT Edges Higher Amid Modest Gains BioLife Solutions BLFS Faces Headwinds Shares Decline 319 to 2395 VICI Properties VICI Holds Steady Near 2850 as REIT Sector Weighs Macro Headwinds Basel Medical Group Ltd BMGL Holds Steady at 058 Consolidation Signals Potential Breakout The RMR Group RMR Edges Higher Testing Resistance at 2126 HCAT Q1 2026 Earnings Health Catalyst Posts EPS Beat Revenue Details Not Disclosed APA Corporation APA Q1 2026 Earnings EPS Surges Past Estimates But Stock Declines Amidst Mixed Signals OP Bancorp Q1 2026 Earnings Earnings Beat Estimates Despite Modest Stock Decline MeiraGTx Holdings plc MGTX Q1 2026 Earnings WiderthanExpected Loss Stings Investors Clear Secure Inc YOU Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Dip PLAB Q1 2026 Earnings EPS Surges 1178 Above Estimates Shares Rally Kazatomprom Reports 17 Production Increase in Third Quarter RCKY Q1 2026 Earnings Earnings Per Share Misses Estimates Stock Declines Slightly PTC Therapeutics PTCT Slips 140 as Biotech Sector Faces Selling Pressure